Lung Cancer Surgery Market - Global Industry Analysis

Lung Cancer Surgery Market By Type (Surgical Instruments, Monitoring & Visualizing Systems, and Endosurgical Equipment), By Procedure (Robotic Surgery, Thoracotomy, Lobectomy, Sleeve Resection, Endobronchial Surgery, Pneumonectomy, Percutaneous Surgery, Segmentectomy, and Minimally Invasive Surgeries), By Treatment (Hospitals, Clinics, Ambulatory Surgical Centers, and Research Laboratories): Global Industry Perspective, Comprehensive Analysis and Forecast, 2021 – 2028

Published Date: 22-Oct-2021 Category: Healthcare Report Format : PDF Pages: 180 Report Code: ZMR-589 Status : Published

The global lung cancer surgery market accounted for USD 5.63 Billion in 2020 and is expected to reach USD 7.59 Billion by 2028, growing at a CAGR of 4.2% from 2021 to 2028.

Description

Global Lung Cancer Surgery Market Size And Industry Analysis

The global lung cancer surgery market accounted for USD 5.63 Billion in 2020 and is expected to reach USD 7.59 Billion by 2028, growing at a CAGR of 4.2% from 2021 to 2028.

Surgery for Lung cancer for some patients is an option depending on the location, stage, and type of lung cancer considering other medical conditions. Efforts to fix lung cancer with surgery can remove tumor with some of the surrounding lung tissue. Tumor removal with lung cancer surgery is treated as the best option if the cancer is unlikely to spread and is localized.

People with a high risk of lung cancer can consider lung cancer screening annually using low-dose CT scans. Screening of Lung cancer is generally suggested to old adults who smoked heavily in their past years or who quit smoking in the past 10-15 years.

Global Lung Cancer Surgery Market Size

COVID-19 Impact Analysis

COVID-19 has affected several sectors including Lung cancer surgery market. One of the main concerns impending is lack of optimal manufacturing capacity across lung cancer surgery market. Due to deviation of medical field towards curing COVID-19, funding to Research & Development activities associated to lung cancer surgery market have declined and this industry have to face negligence afterwards causing unfavorable impact on the market

The number of diagnostic procedures and cancer screening declined rashly, with nations affected by the virus.

Growth Factors

Introduction of AI in healthcare sector has been driving adoption ratio of RATSS (robotic-assisted thoracic surgery systems). The segment is anticipated to contribute substantially to lung cancer surgery industry globally, in terms of revenue. Up gradation in treatment of lung cancer and growing technological advancement is the essential factor expanding the growth of the market, also awareness levels are high among the people about treatment of cancer, an increase in the retiree population, rise in pollution levels due to cigarette smokers across the globe and increase in government funding for R&D of new treatment procedures and drugs are the key factors propelling lung cancer surgery market.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Product Analysis Preview

In 2020, surgical instruments segment estimated for the biggest market share due to increasing incidence and prevalence of lung cancer, increasing government funding and support, and the rising adoption of surgical procedures for treating lung cancer are the key factors propelling the market growth. Surgical Instruments, Monitoring & Visualizing Systems, Endosurgical Equipment form Type segment of Lung Cancer Surgery Market.

Global Lung Cancer Surgery Market Share

Flavor Segment Analysis Preview

Thoracotomy segment held the largest share in the lung cancer surgery industry. However, minimally invasive surgeries segment is anticipated to rise at the topmost during the coming years. The increasing acceptance of minimally invasive surgery techniques, presence of reimbursement policies, rising technological advancements and the rising trend of robotic surgeries are some of the key factors fueling the growth of minimally invasive surgeries segment. Robotic Surgery, Lobectomy, Thoracotomy, Endobronchial Surgery, Sleeve Resection, Percutaneous Surgery, Pneumonectomy, Minimally Invasive Surgeries, and Segmentectomy form the Procedure Segment of Lung Cancer Surgery Market.

Regional Analysis Preview

The North American region held a share of over 33% in 2020. The region dominates lung cancer surgery market owing to an increase in the level of awareness among the common population about treatment of cancer, and senior citizen population in the region.

Asia Pacific is anticipated to grow at a CAGR of 7.6% over the forecast period. Asia Pacific Lung surgery market is expected to rise on account of increasing favorable initiatives by government, increasing occurrence of lung cancer, and growing healthcare expenditure.

Global Lung Cancer Surgery Market Regional Analysis

Key Market Players & Competitive Landscape

Some of key players in Lung Cancer Surgery Market are Intuitive Surgical, Medical Devices Business Services, Inc., Olympus Corporation, AngioDynamics, Scanlan International, KARL STORZ SE & Co. KG, TROKAMED GmbH, F.Hoffmann-La Roche Ltd., Pfizer Inc., Abbott, Boehringer Ingelheim International GmbH, Genentech Inc., Boston Scientific Corporation, among others. 

The Global Lung Cancer Surgery Market is segmented as follows:

By Type

  • Surgical Instruments
  • Monitoring & Visualizing Systems
  • Endosurgical Equipment

By Procedure

  • Robotic Surgery
  • Thoracotomy
  • Lobectomy
  • Sleeve Resection
  • Endobronchial Surgery
  • Pneumonectomy
  • Percutaneous Surgery
  • Segmentectomy
  • Minimally Invasive Surgeries

By Treatment

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Research Laboratories

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1: Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2: Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Type
        • 2.1.1.2. Market Attractiveness Analysis, By Procedure
        • 2.1.1.3. Market Attractiveness Analysis, By Treatment
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Lung Cancer Surgery Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3: COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4: Lung Cancer Surgery Market – Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Type, 2020 & 2028
    • 4.2. Surgical Instruments
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Monitoring & Visualizing Systems
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Endosurgical Equipment
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5: Lung Cancer Surgery Market – Procedure Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Procedure, 2020 & 2028
    • 5.2. Robotic Surgery
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Thoracotomy
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Lobectomy
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Sleeve Resection
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Endobronchial Surgery
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Pneumonectomy
      • 5.7.1. Market Size and Forecast, By Region (USD Million)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. Percutaneous Surgery
      • 5.8.1. Market Size and Forecast, By Region (USD Million)
      • 5.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.9. Segmentectomy
      • 5.9.1. Market Size and Forecast, By Region (USD Million)
      • 5.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.10. Minimally Invasive Surgeries
      • 5.10.1. Market Size and Forecast, By Region (USD Million)
      • 5.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.10.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6: Lung Cancer Surgery Market – Treatment Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Treatment, 2020 & 2028
    • 6.2. Hospitals
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Clinics
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Ambulatory Surgical Centers
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Research Laboratories
      • 6.5.1. Market Size and Forecast, By Region (USD Million)
      • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7: Lung Cancer Surgery Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Type, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Procedure, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Treatment, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Type, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Procedure, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Treatment, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Type, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Procedure, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Treatment, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Type, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Procedure, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Treatment, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Type, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Procedure, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Treatment, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Type, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Procedure, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Treatment, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Type, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Procedure, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Treatment, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Type, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Procedure, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Treatment, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Type, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Procedure, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Treatment, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Type, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Procedure, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Treatment, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Type, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Procedure, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Treatment, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Type, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Procedure, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Treatment, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Type, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Procedure, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Treatment, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Type, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Procedure, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Treatment, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Type, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Procedure, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Treatment, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Type, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Procedure, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Treatment, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Type, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Procedure, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Treatment, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Type, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Procedure, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Treatment, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Type, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Procedure, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Treatment, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Type, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Procedure, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Treatment, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Type, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Procedure, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Treatment, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Type, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Procedure, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Treatment, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Type, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Procedure, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Treatment, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Type, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Procedure, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Treatment, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Type, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Procedure, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Treatment, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Type, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Procedure, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Treatment, 2016 – 2028
  • Chapter No. 8: Lung Cancer Surgery Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
    • 8.3. Market Restraints
    • 8.4. Market Opportunities
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technulogy Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9: Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Lung Cancer Surgery Market: Company Market Share, 2019
      • 9.1.2. Global Lung Cancer Surgery Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Lung Cancer Surgery Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Lung Cancer Surgery Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10: Company Profiles
    • 10.1. Medical Devices Business Services, Inc.
    • 10.2. Intuitive Surgical
    • 10.3. AngioDynamics
    • 10.4. ulympus Corporation
    • 10.5. KARL STORZ SE & Co. KG
    • 10.6. Scanlan International
    • 10.7. TROKAMED GmbH
    • 10.8. Pfizer Inc.
      • 10.9. F.Hoffmann-La Roche Ltd.
    • 10.10. Genentech Inc.
    • 10.11. Boehringer Ingelheim International GmbH
    • 10.12. Abbott
    • 10.13. Boston Scientific Corporation
  • Chapter No. 11: Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12: Research Methodulogy
    • 12.1. Research Methodulogy
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Table Of Figures

List of Figures    

FIG NO. 1. Market Attractiveness Analysis, By Type
FIG NO. 2. Market Attractiveness Analysis, By Procedure
FIG NO. 3. Market Attractiveness Analysis, By Treatment
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Lung Cancer Surgery Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Type, 2020 & 2028
FIG NO. 8. Global Lung Cancer Surgery Market for Surgical Instruments, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Lung Cancer Surgery Market for Surgical Instruments, By Country, 2020 & 2028
FIG NO. 10. Global Lung Cancer Surgery Market for Monitoring & Visualizing Systems, Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Lung Cancer Surgery Market for Monitoring & Visualizing Systems, By Country, 2020 & 2028
FIG NO. 12. Global Lung Cancer Surgery Market for Endosurgical Equipment, Revenue (USD Million) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Lung Cancer Surgery Market for Endosurgical Equipment, By Country, 2020 & 2028
FIG NO. 14. Market Revenue Share, By Procedure, 2020 & 2028
FIG NO. 15. Global Lung Cancer Surgery Market for Robotic Surgery, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Lung Cancer Surgery Market for Robotic Surgery, By Country, 2020 & 2028
FIG NO. 17. Global Lung Cancer Surgery Market for Thoracotomy, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Lung Cancer Surgery Market for Thoracotomy, By Country, 2020 & 2028
FIG NO. 19. Global Lung Cancer Surgery Market for Lobectomy, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Lung Cancer Surgery Market for Lobectomy, By Country, 2020 & 2028
FIG NO. 21. Global Lung Cancer Surgery Market for Sleeve Resection, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Lung Cancer Surgery Market for Sleeve Resection, By Country, 2020 & 2028
FIG NO. 23. Global Lung Cancer Surgery Market for Endobronchial Surgery, Revenue (USD Million) 2016 – 2028
FIG NO. 24. Comparative Revenue Analysis of Lung Cancer Surgery Market for Endobronchial Surgery, By Country, 2020 & 2028
FIG NO. 25. Global Lung Cancer Surgery Market for Pneumonectomy, Revenue (USD Million) 2016 – 2028
FIG NO. 26. Comparative Revenue Analysis of Lung Cancer Surgery Market for Pneumonectomy, By Country, 2020 & 2028
FIG NO. 27. Global Lung Cancer Surgery Market for Percutaneous Surgery, Revenue (USD Million) 2016 – 2028
FIG NO. 28. Comparative Revenue Analysis of Lung Cancer Surgery Market for Percutaneous Surgery, By Country, 2020 & 2028
FIG NO. 29. Global Lung Cancer Surgery Market for Segmentectomy, Revenue (USD Million) 2016 – 2028
FIG NO. 30. Comparative Revenue Analysis of Lung Cancer Surgery Market for Segmentectomy, By Country, 2020 & 2028
FIG NO. 31. Global Lung Cancer Surgery Market for Minimally Invasive Surgeries, Revenue (USD Million) 2016 – 2028
FIG NO. 32. Comparative Revenue Analysis of Lung Cancer Surgery Market for Minimally Invasive Surgeries, By Country, 2020 & 2028
FIG NO. 33. Market Revenue Share, By Treatment, 2020 & 2028
FIG NO. 34. Global Lung Cancer Surgery Market for Hospitals, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Lung Cancer Surgery Market for Hospitals, By Country, 2020 & 2028
FIG NO. 36. Global Lung Cancer Surgery Market for Clinics, Revenue (USD Million) 2016 – 2028
FIG NO. 37. Comparative Revenue Analysis of Lung Cancer Surgery Market for Clinics, By Country, 2020 & 2028
FIG NO. 38. Global Lung Cancer Surgery Market for Ambulatory Surgical Centers, Revenue (USD Million) 2016 – 2028
FIG NO. 39. Comparative Revenue Analysis of Lung Cancer Surgery Market for Ambulatory Surgical Centers, By Country, 2020 & 2028
FIG NO. 40. Global Lung Cancer Surgery Market for Research Laboratories, Revenue (USD Million) 2016 – 2028
FIG NO. 41. Comparative Revenue Analysis of Lung Cancer Surgery Market for Research Laboratories, By Country, 2020 & 2028
FIG NO. 42. Global Lung Cancer Surgery Market Revenue Share, By Region, 2020 & 2028
FIG NO. 43. North America Lung Cancer Surgery Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 44. Porter’s Five Forces Analysis for Global Lung Cancer Surgery Market
FIG NO. 45. PEST Analysis for Global Lung Cancer Surgery Market
FIG NO. 46. Pricing Analysis for Global Lung Cancer Surgery Market
FIG NO. 47. Value Chain Analysis for Global Lung Cancer Surgery Market
FIG NO. 48. Company Share Analysis, 2019
FIG NO. 49. Radar Determinant Chart, 2019
FIG NO. 50. Company Strategic Developments – Heat Map Analysis
FIG NO. 51. Medical Devices Business Services, Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 52. Medical Devices Business Services, Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 53. Market Channels
FIG NO. 54. Marketing Channel Development Trend
FIG NO. 55. Growth in World Gross Product, 2008-2018
FIG NO. 56. Research Methodology – Detailed View
FIG NO. 57. Research Methodology


Table Of Tables

List of Tables 

TABLE NO. 1. Global Lung Cancer Surgery Market: Snapshot
TABLE NO. 2. Quarterly Lung Cancer Surgery Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Lung Cancer Surgery Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Lung Cancer Surgery Market for Surgical Instruments, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Lung Cancer Surgery Market for Monitoring & Visualizing Systems, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Lung Cancer Surgery Market for Endosurgical Equipment, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Lung Cancer Surgery Market for Robotic Surgery, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Lung Cancer Surgery Market for Thoracotomy, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Lung Cancer Surgery Market for Lobectomy, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Lung Cancer Surgery Market for Sleeve Resection, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Lung Cancer Surgery Market for Endobronchial Surgery, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Lung Cancer Surgery Market for Pneumonectomy, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Lung Cancer Surgery Market for Percutaneous Surgery, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Lung Cancer Surgery Market for Segmentectomy, by Region, 2016 – 2028 (USD Million)
TABLE NO. 17. Global Lung Cancer Surgery Market for Minimally Invasive Surgeries, by Region, 2016 – 2028 (USD Million)
TABLE NO. 18. Global Lung Cancer Surgery Market for Hospitals, by Region, 2016 – 2028 (USD Million)
TABLE NO. 19. Global Lung Cancer Surgery Market for Clinics, by Region, 2016 – 2028 (USD Million)
TABLE NO. 20. Global Lung Cancer Surgery Market for Ambulatory Surgical Centers, by Region, 2016 – 2028 (USD Million)
TABLE NO. 21. Global Lung Cancer Surgery Market for Research Laboratories, by Region, 2016 – 2028 (USD Million)
TABLE NO. 22. Global Lung Cancer Surgery Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 23. North America Lung Cancer Surgery Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 24. North America Lung Cancer Surgery Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 25. North America Lung Cancer Surgery Market Revenue, By Procedure, 2016 – 2028 (USD Million)
TABLE NO. 26. North America Lung Cancer Surgery Market Revenue, By Treatment, 2016 – 2028 (USD Million)
TABLE NO. 27. U.S. Lung Cancer Surgery Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 28. U.S. Lung Cancer Surgery Market Revenue, By Procedure, 2016 – 2028 (USD Million)
TABLE NO. 29. U.S. Lung Cancer Surgery Market Revenue, By Treatment, 2016 – 2028 (USD Million)
TABLE NO. 30. Canada Lung Cancer Surgery Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 31. Canada Lung Cancer Surgery Market Revenue, By Procedure, 2016 – 2028 (USD Million)
TABLE NO. 32. Canada Lung Cancer Surgery Market Revenue, By Treatment, 2016 – 2028 (USD Million)
TABLE NO. 33. Mexico Lung Cancer Surgery Market Revenue, By Type, 2016 – 2028 (USD Million)
TABLE NO. 34. Mexico Lung Cancer Surgery Market Revenue, By Procedure, 2016 – 2028 (USD Million)
TABLE NO. 35. Mexico Lung Cancer Surgery Market Revenue, By Treatment, 2016 – 2028 (USD Million)
TABLE NO. 36. Drivers for the Lung Cancer Surgery Market: Impact Analysis
TABLE NO. 37. Restraints for the Lung Cancer Surgery Market: Impact Analysis
TABLE NO. 38. Major Buyers of Lung Cancer Surgery
TABLE NO. 39. Distributors/Traders List of Lung Cancer Surgery
TABLE NO. 40. Global Lung Cancer Surgery Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 41. Global Lung Cancer Surgery Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The Global Lung Cancer Surgery Market was valued at USD 5.63 Billion in 2020.

The Global Lung Cancer Surgery Market is expected to reach USD7.59 Billion by 2028, growing at a CAGR of 4.2% between 2021 to 2028.

Some of the key factors driving the Global Lung Cancer Surgery Market growth are increasing senior citizen population, growing pollution due to rising smokers, and increasing women smokers population, among others.

 

North America region held a substantial share of the Lung Cancer Surgery Market in 2020. Asia Pacific to grow at a substantial rate.

Some of the major companies operating in the Cigars and Cigarillos market are Intuitive Surgical, Medical Devices Business Services, Inc., Olympus Corporation, AngioDynamics, Scanlan International, KARL STORZ SE & Co. KG, TROKAMED GmbH, F.Hoffmann-La Roche Ltd., Pfizer Inc., Abbott, Boehringer Ingelheim International GmbH, Genentech Inc., Boston Scientific Corporation, among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed